Skip to Main Content

Paper Details

Small-molecule BCL6 inhibitor effectively treats mice with nonsclerodermatous chronic graft-versus-host disease.
Blood
19
2019
B cells, B-cell lymphoma 6, BCL6, BTB, Bric-abrac, Broad-complex, GC B cells, Patient, T follicular helper cells, Tramtrack, bronchiolitis obliterans, cGVHD, chronic graft-versus-host diesease, donor T cells, ibrutinib, immune cells, mice, mouse, multiorgan system injury, nonsclerodermatous chronic graft-versus-host disease, patients, scleroderma, zinc
Author NameAffiliation
Ryan A FlynnUniversity of Minnesota
Jun QiDana-Farber Cancer Institute, Harvard Medical School
Jun QiHarvard Medical School
Jonathan S SerodyLineberger Comprehensive Cancer Center, University of North Carolina
William J Murphy
William J MurphyUniversity of California Davis Medical Center
Peter T SageHarvard Medical School
Jerome RitzDana-Farber Cancer Institute, Harvard Medical School
James E BradnerDana-Farber Cancer Institute, Harvard Medical School
James E BradnerHarvard Medical School
James E BradnerNovartis Institutes for Biomedical Research
Ari MelnickCornell University
  • 1 - 12

Datasets

Release 1.2